Cite
Antihypertensive Medication Use before and during Pregnancy and the Risk of Severe Maternal Morbidity in Individuals with Prepregnancy Hypertension
MLA
Shalmali Bane, et al. “Antihypertensive Medication Use before and during Pregnancy and the Risk of Severe Maternal Morbidity in Individuals with Prepregnancy Hypertension.” American Journal of Perinatology, Oct. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e79e742d1ea146fb5bc9d706f85b0be8&authtype=sso&custid=ns315887.
APA
Shalmali Bane, Elizabeth Wall-Wieler, Maurice L. Druzin, & Suzan L. Carmichael. (2022). Antihypertensive Medication Use before and during Pregnancy and the Risk of Severe Maternal Morbidity in Individuals with Prepregnancy Hypertension. American Journal of Perinatology.
Chicago
Shalmali Bane, Elizabeth Wall-Wieler, Maurice L. Druzin, and Suzan L. Carmichael. 2022. “Antihypertensive Medication Use before and during Pregnancy and the Risk of Severe Maternal Morbidity in Individuals with Prepregnancy Hypertension.” American Journal of Perinatology, October. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e79e742d1ea146fb5bc9d706f85b0be8&authtype=sso&custid=ns315887.